Skip to main content

Studies / Research

Clinical Trials

Biocept is dedicated to supporting its partners, collaborators, and clients with our unique CNSide™ CSF-TC and cfDNA technology platforms for rare event detection and genetic characterization. Our CLIA-licensed and CAP-accredited laboratory combines a highly trained professional staff who are experienced in assay development with innovative instrumentation for optimal test results and quality control.

Our CNSide™ platforms provide flexibility for developing assays with unique requirements for our partners. This development can be performed in our CLIA laboratory.  We focus on providing high-level, personalized service to our clients, addressing critical questions of interest to them including:

  • Assay development
  • Patient population profiling
  • Determination of patient eligibility/stratification for clinical trials
  • Measuring efficacy endpoints
  • Correlative science studies

Please contact Clinical Affairs for more information at 888.332.7729 or via email at

How Biocept is Creating the Future

We’re building partnerships that redefine the boundaries of personalized cancer medicine.

Learn More